Characteristics | DLB (APOE ε4 carriers vs. non-carriers) | PDD (APOE ε4 carriers vs. non-carriers) | ||||
---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95%CI | P-value | |
OH | 1.488 | 0.496–4.461 | 0.478 | 1.790 | 0.426–7.520 | 0.525 |
Constipation | 0.977 | 0.341–2.800 | 0.961 | 1.435 | 0.383–5.383 | 0.592 |
Urinary Symptoms | 1.452 | 0.448–4.702 | 0.534 | 0.773 | 0.141–2.244 | 0.767 |
HH | 3.472 | 1.082–11.144 | 0.036 | 0.470 | 0.050–4.450 | 0.510 |
Falls | 1.342 | 0.407–4.428 | 0.629 | 1.790 | 0.426–7.520 | 0.427 |
FoF | 0.755 | 0.229–2.484 | 0.644 | 1.033 | 0.262–4.067 | 0.963 |
Delusion | 1.923 | 0.669–5.527 | 0.225 | 0.000 | 0.000–0.000 | 0.998 |
Depression | 3.002 | 1.079–8.353 | 0.035 | 2.110 | 0.473–9.410 | 0.328 |
Anxiety | 1.358 | 0.565–3.266 | 0.494 | 1.475 | 0.309–7.052 | 0.626 |
Apathy | 1.925 | 0.760–4.879 | 0.167 | 0.655 | 0.068–6.277 | 0.714 |
Loss of appetite | 1.311 | 0.499–3.446 | 0.582 | 0.000 | 0.000–0.000 | 0.997 |
Insomnia | 1.978 | 0.671–5.824 | 0.216 | 1.838 | 0.455–7.427 | 0.393 |
EDS | 0.552 | 0.162–1.884 | 0.343 | 1.375 | 0.208–9.091 | 0.741 |